pET28a-mH6-Cas12c2 Citations (3)

Originally described in: Functionally diverse type V CRISPR-Cas systems.
Yan WX, Hunnewell P, Alfonse LE, Carte JM, Keston-Smith E, Sothiselvam S, Garrity AJ, Chong S, Makarova KS, Koonin EV, Cheng DR, Scott DA Science. 2019 Jan 4;363(6422):88-91. doi: 10.1126/science.aav7271. Epub 2018 Dec 6. PubMed Journal

---

Articles Citing pET28a-mH6-Cas12c2

Articles
Structure of the type V-C CRISPR-Cas effector enzyme. Kurihara N, Nakagawa R, Hirano H, Okazaki S, Tomita A, Kobayashi K, Kusakizako T, Nishizawa T, Yamashita K, Scott DA, Nishimasu H, Nureki O. Mol Cell. 2022 May 19;82(10):1865-1877.e4. doi: 10.1016/j.molcel.2022.03.006. Epub 2022 Apr 1. PubMed
The lysine methyltransferase SMYD5 amplifies HIV-1 transcription and is post-transcriptionally upregulated by Tat and USP11. Boehm D, Lam V, Schnolzer M, Ott M. Cell Rep. 2023 Mar 28;42(3):112234. doi: 10.1016/j.celrep.2023.112234. Epub 2023 Mar 9. PubMed
A flow cytometry-based assay to investigate HIV-1 expression in SMYD5 shRNA containing primary CD4(+) T cells. Boehm D, Ott M. STAR Protoc. 2023 Dec 15;4(4):102694. doi: 10.1016/j.xpro.2023.102694. Epub 2023 Nov 9. PubMed

If you have published an article using this material, please email us at to have your article added to this page.